跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation
Approved
STANDARD
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation
AstraZeneca AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c9e654569cf411dd
Company
AstraZeneca AB
Type
Standard
Approval Details
Approval Id
c9e654569cf411dd
Drug Approval Philippines Name
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation
Product Name
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation
Registration Number
DR-XY27296
Brand Name
Symbicort Turbuhaler® 160 Mcg/4.5 Mcg Per Dose Powder For Inhalation
Generic Name
Budesonide/ Formoterol Fumarate Dihydrate
Dosage Form
Powder For Inhalation
Dosage Strength
160mcg/ 4.5mcg per dose
Manufacturer
AstraZeneca AB
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/astrazeneca-ab
Issuance Date
26 March 2022
Expiry Date
06 July 2027
Pharmacologic Category
Anti-asthma
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c9e654569cf411dd
Type
Standard
Back to Philippines FDA Approvals